15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Novocure Ltd, 2 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $17.00 to $46.00 (about 2.7x), a sign of real disagreement on valuation. The average target of $23.60 sits 45% above the current $16.32. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 2 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.25 next quarter toward $-0.80 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Moderate Buy
Strong Buy00%
Buy240%
Hold360%
Sell00%
Strong Sell00%
Based on 5 analysts giving stock ratings to Novocure Ltd.
As of Jul, 2 of 5 firms rate NVCR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NVCR EPS & revenue forecast
EPS · NEXT QUARTER
$-0.25
Range $-0.31 – $-0.15 · 6 analysts · +14% YoY
Next period, 6 analysts expect Novocure Ltd to earn $-0.25 a share (range $-0.31 – $-0.15), versus $-0.22 a year earlier. Full-year consensus is $-1.26, growing to $-0.80 the year after.
REVENUE · NEXT QUARTER
$184.7M
Range $180.7M – $186.9M · 6 analysts · +6% YoY
Revenue is expected to reach $184.7M (range $180.7M – $186.9M), +6.0% year-over-year. Full-year consensus is $723.9M, rising to $811.2M next year.
Top analysts covering Novocure Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NVCR.
#1
Jessica Fye
JP Morgan · Rank #64
Hold
$17.00+4.2% to target
Overall win rate
52%
+ Follow
#2
David Nierengarten
Wedbush · Rank #115
Hold
$18.00+10.3% to target
Overall win rate
41%
+ Follow
#3
Jason Bednar
Piper Sandler · Rank #303
Buy
$27.00+65.4% to target
Overall win rate
33%
+ Follow
#4
Emily Bodnar
HC Wainwright & Co. · Rank #338
Buy
$46.00+181.9% to target
Overall win rate
22%
+ Follow
#5
Vijay Kumar
Evercore ISI Group
Buy
$20.00+22.5% to target
Coverage
—
+ Follow
NVCR stock forecast FAQ
What is NVCR's average 12-month price target?+
The 5 analysts with a live target average $23.60 for Novocure Ltd over the next 12 months, ranging from a $46.00 high to a $17.00 low.
Is NVCR stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 5 analyst ratings, 2 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NVCR?+
The Street-high target is $46.00 (HC Wainwright & Co.), and the Street-low is $17.00 (JP Morgan). The average of all 5 active targets is $23.60.
How many Wall Street analysts cover NVCR?+
5 analysts have an active rating on Novocure Ltd, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering NVCR?+
Among analysts who currently cover NVCR, Jessica Fye of JP Morgan has the strongest overall Quantellect track record (Rank #64). Their current call is Hold with a $17.00 target.
What is Novocure Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.25 per share (range $-0.31 – $-0.15) across 6 analysts. Full-year EPS is projected at $-1.26, rising to $-0.80 the following year.
How much revenue is Novocure Ltd expected to report next quarter?+
Consensus revenue is $184.7M (range $180.7M – $186.9M). Full-year revenue is projected at $723.9M, growing to $811.2M next year.
Have analysts been upgrading or downgrading NVCR lately?+
As of Jul, 2 of 5 firms rate NVCR a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NVCR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
